Jurjees Hasan

Manchester, ENG M204BX, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol.

Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol.

Journal: Clinical and experimental medicine

Published: December 15, 2025

Exploring perceptual disparities: A study on the level of understanding of colorectal cancer care among patients and healthcare professionals.

Exploring perceptual disparities: A study on the level of understanding of colorectal cancer care among patients and healthcare professionals.

Journal: International journal of colorectal disease

Published: July 16, 2025

Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study.

Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study.

Journal: Clinical colorectal cancer

Published: May 30, 2025

Homologous recombination deficiency in unselected cases of high-grade ovarian carcinoma.

Homologous recombination deficiency in unselected cases of high-grade ovarian carcinoma.

Journal: Journal of medical genetics

Published: May 05, 2025

Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SM.

Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SM.

Journal: Current oncology (Toronto, Ont.)

Published: October 17, 2024

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.

Journal: British journal of cancer

Published: May 26, 2024

Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.

Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 09, 2024

Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene.

Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: April 13, 2024

Is early-onset colorectal cancer an evolving pandemic? Real-world data from a tertiary cancer center.

Is early-onset colorectal cancer an evolving pandemic? Real-world data from a tertiary cancer center.

Journal: The oncologist

Published: February 25, 2024

Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian Cancer.

Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian Cancer.

Journal: Cancers

Published: November 24, 2023

The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM Study.

The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM Study.

Journal: Cancers

Published: January 20, 2023

Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?

Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?

Journal: Cancers

Published: December 04, 2022

Showing 1-12 of 42

Last Updated: 09/26/2026